FIVE QUESTIONS little bit more to a wellness-type customer. We see a lot of CBN in the edibles category as well as ingestibles like tinctures and capsules. CBN, especially, is seen as more of a wellness-type cannabinoid. Customers are potentially looking more to treat symptoms/ get better sleep (with CBN), and that tends to translate to noninhalable categories. Edibles may be more approachable for new (cannabis) users or those looking to treat insomnia or treat pain. What do you think caused the rapid decline in D-8 sales starting in 2021? We can see that delta-8 sales exploded in late 2020 and continued to grow through Q2 of Ashley Cooper 2021, but in Q3 (they took) a pretty significant nosedive. There were a few quarters when (D-8) growth was quick-probably because it was gaining popularity, and also it was quite unregulated. Since it gained popularity, state governments have been forced to try to deal with it-and some have banned it (including Washington state, which is included in the chart on page 12). Now that it is more regulated, I think that level of growth has been naturally curtailed. How do D-8 prices compare with other items you track? It appears that customers who are looking for delta-8 products will have to shell out a bit more cash to get them. Over the previous 90 days, the average item price of a delta-8 edible product was about 24% higher than a non-delta-8 THC edible. This interview has been edited for length and clarity.http://www.fltled.com